Company news

Novavax, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Novavax Initiates Efficacy Trial of COVID-19 Vaccine in South Africa

August 16, 2020

Novavax and UK Government Announce Collaboration and Purchase Agreement for Novavax’ COVID-19 Vaccine Candidate

August 13, 2020

Novavax and SK bioscience Announce Collaboration for Novavax’ COVID-19 Vaccine Candidate

August 12, 2020

Novavax Reports Second Quarter 2020 Financial and Operational Results

August 9, 2020

Novavax and Takeda Announce Collaboration for Novavax’ COVID-19 Vaccine Candidate in Japan

August 6, 2020

Novavax and Serum Institute of India Announce Development and Commercial Collaboration

August 5, 2020

Novavax Announces Positive Phase 1 Data for its COVID-19 Vaccine Candidate

August 3, 2020

Novavax and FUJIFILM Diosynth Biotechnologies Initiate Large Scale Manufacturing of COVID-19 Vaccine Candidate

July 22, 2020

Novavax Announces $1.6 Billion Funding from Operation Warp Speed

July 6, 2020

Novavax Announces Updates to Leadership Team

July 1, 2020

Novavax Expands Executive Leadership and Announces Key Promotions

June 28, 2020

Novavax Announces Additions to Executive Leadership

June 16, 2020

Novavax Appoints Biotechnology Veteran David Mott to Board of Directors

June 15, 2020

Novavax to Raise $200 Million from Private Placement with RA Capital

June 14, 2020

Novavax Awarded Department of Defense Contract for COVID-19 Vaccine

June 3, 2020

Novavax Expands Large-Scale Global Manufacturing Capacity

May 26, 2020

Novavax Initiates Phase 1/2 Clinical Trial of COVID-19 Vaccine

May 24, 2020

Novavax Reports First Quarter 2020 Financial Results

May 10, 2020

Novavax Identifies Coronavirus Vaccine Candidate; Accelerates Initiation of First-in-Human Trial to Mid-May

April 7, 2020

Novavax’ NanoFlu Achieves All Primary Endpoints In Phase 3 Clinical Trial

March 23, 2020

Novavax Reports Fourth Quarter and Full Year 2019 Financial Results

March 10, 2020

Novavax Awarded Funding from CEPI for COVID-19 Vaccine Development

March 9, 2020

Novavax Advances Development of Novel COVID-19 Vaccine

February 25, 2020

Novavax Granted Fast Track Designation for NanoFlu in Older Adults

January 14, 2020

Novavax Reports Third Quarter 2019 Financial Results

November 6, 2019

Novavax Initiates Pivotal Phase 3 Clinical Trial of NanoFlu Influenza Vaccine in Older Adults

October 14, 2019

← Newer news releases

Calls

The 5 newest of 23 calls. Every call is listed under its year.

Decks

The 5 newest of 69 decks. Every deck is listed under its year.